Novo Nordisk A/S vs Teladoc Health Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: Novo Nordisk A/S is far larger — about 126.7× Teladoc Health Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| NVO | TDOC | |
|---|---|---|
Market Cap | $220.53B | $1.74B |
Sector | Health | Health |
52-Week High | $71.70 | $9.72 |
52-Week Low | $35.29 | $4.47 |
Enterprise Value | $239.49B | $2.03B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →